These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 2114331)
1. Magnetic resonance imaging in Canada. Reese L Dimens Health Serv; 1990 Mar; 67(2):10-4. PubMed ID: 2114331 [No Abstract] [Full Text] [Related]
2. [Role of magnetic resonance in the identification, characterization and staging of prostatic cancer. Comparison with transrectal echotomography and computerized tomography]. Gualdi GF; Volpe A; Polettini E; Ceroni AM; D'Agostino A; Capuano R Clin Ter; 1994 Mar; 144(3):241-9. PubMed ID: 8181221 [TBL] [Abstract][Full Text] [Related]
3. Evaluating the role of transrectal ultrasonography and magnetic resonance imaging in prostate carcinoma. Chang PJ Curr Opin Radiol; 1991 Oct; 3(5):687-93. PubMed ID: 1931504 [TBL] [Abstract][Full Text] [Related]
5. Staging of localized prostate cancer: a clinical-pathologic correlation. Mukamel E; de Kernion JB; Hannah J; Barbaric Z J Urol (Paris); 1988; 94(8):381-8. PubMed ID: 3241091 [TBL] [Abstract][Full Text] [Related]
6. [Lymph node staging in prostatic and bladder carcinomas--a radiological dilemma]. Hamm B Rofo; 1994 Jul; 161(1):1-2. PubMed ID: 8043757 [No Abstract] [Full Text] [Related]
7. [Staging of prostatic carcinoma. Accuracy of magnetic resonance]. Biondetti PR; Lee JK; Ling D; Vigo M; Fiore D; Macchi C; Borasi G Radiol Med; 1987 Sep; 74(3):204-8. PubMed ID: 3659429 [TBL] [Abstract][Full Text] [Related]
8. Clinical staging in carcinoma of the prostate: current aspects. Schmitz-Dräger BJ; Ebert T; Ackermann R Recent Results Cancer Res; 1993; 126():30-42. PubMed ID: 8456193 [No Abstract] [Full Text] [Related]
9. Ultrasonographic features of prostatic carcinoma. Greenberg M; Neimen HL; Vogelzang R; Falkowski W J Clin Ultrasound; 1982 Sep; 10(7):307-12. PubMed ID: 6815228 [TBL] [Abstract][Full Text] [Related]
10. [X-ray computed tomography, MRI and transrectal echography of cancer of the prostate]. Laval-Jeantet M; Tobolski F; Le Duc A; Teillac P Pathol Biol (Paris); 1989 Feb; 37(2):107-8. PubMed ID: 2652053 [No Abstract] [Full Text] [Related]
11. The role of CT in the staging and radiotherapy planning of prostatic tumours. Dobbs HJ; Husband JE Br J Radiol; 1985 May; 58(689):429-36. PubMed ID: 4063691 [TBL] [Abstract][Full Text] [Related]
12. [Current role of conventional tomography in the staging of pulmonary neoplasms. Reflections based on the comparison of tomography-magnetic resonance in 81 cases]. Castoldi MC; Danesini GM; Balzarini L; Bergonzi S; Laffranchi A; Guzzon A Radiol Med; 1991 Oct; 82(4):437-42. PubMed ID: 1767049 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of endorectal magnetic resonance imaging for the staging of prostate cancer. Langlotz CP; Schnall MD; Malkowicz SB; Schwartz JS Acad Radiol; 1996 Apr; 3 Suppl 1():S24-7. PubMed ID: 8796502 [No Abstract] [Full Text] [Related]
14. Magnetic resonance imaging (MRI) in staging of the prostatic cancer. Javadpour N; Campbell EW; Young JD Prog Clin Biol Res; 1987; 243B():77-87. PubMed ID: 3659053 [TBL] [Abstract][Full Text] [Related]
15. Noninvasive imaging for staging of prostate cancer: magnetic resonance imaging, computed tomography, and ultrasound. Hricak H NCI Monogr; 1988; (7):31-5. PubMed ID: 3050540 [TBL] [Abstract][Full Text] [Related]